Home LiteratureArticle Details
PMID: 15565575 Published · ppublish English Evaluation Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma.

Cancer ·Vol. 103 ·No. 1 ·2005-01-01 ·Pages 164-73

Fisher ER, Anderson S, Dean S, Dabbs D, Fisher B, Siderits R, Pritchard J, Pereira T, Geyer C, Wolmark N

Abstract

The authors attempted to resolve the dilemma posed by the lack of unanimity concerning the optimal immunohistochemical (IHC) method for determining and scoring estrogen receptor (ER) and progesterone receptor (PR). Sections for IHC were prepared from paraffin embedded tumor samples from 402 patients with lymph node positive breast carcinoma who had biochemical receptor values (obtained with the dextran-coated charcoal [DCC] method) and who were enrolled in a prospective, randomized trial (National Surgical Adjuvant Breast and Bowel Project protocol B-09). IHC receptors were scored independently by two observers according to percent, intensity, and any-or-none algorithms. Results from these evaluations and from two computer-assisted evaluations, DCC, and common pathologic characteristics were analyzed for optimum splits for positive reactions in univariate and multivariate analyses using a tree-structured model. Concordance, sensitivity, and specificity were determined between the DCC method and all other methods. Interobserver agreement and concordance between the DCC method and the other methods and among the methods were high. Univariate analyses revealed that a positive ER score obtained with all methods was related significantly to overall survival (OS) at 5 years and at 10 years. Results related to PR scores and disease-free survival and recurrence-free survival were less consistent. In multivariate analysis, it also was found that all methods for scoring ER predicted a better prognosis for OS in patients with an unfavorable lymph node status at 5 years and 10 years. Patients in a favorable lymph node status group were discriminated further by nuclear grade. All IHC methods for scoring ER appeared valid as prognostic indicators of OS in patients with positive lymph nodes. The any-or-none IHC method, by virtue of its simplicity, represents an appropriate choice for practical use.

MeSH Terms
Breast Neoplasms/pathology Charcoal Dextrans Disease-Free Survival Female Follow-Up Studies Humans Immunohistochemistry/methods Lymphatic Metastasis Neoplasm Invasiveness Observer Variation Prognosis Prospective Studies Receptors, Estrogen/analysis Receptors, Progesterone/analysis Sensitivity and Specificity Specimen Handling
Chemicals
Dextrans Receptors, Estrogen Receptors, Progesterone Charcoal
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Fisher Edwin R
National Surgical Adjuvant Breast and Bowel Project Pathology Center and Allegheny General Hospital, West Penn Allegheny Health System, Pittsburgh, Pennsylvania 15212, USA. [email protected]
Anderson Stewart
Dean Scott
Dabbs David
Fisher Bernard
Siderits Richard
Pritchard Jeffrey
Pereira Telma
Geyer Charles
Wolmark Norman
Article Info
Journal
Cancer
Abbr.
Cancer
ISSN
0008-543X
Published
2005-01-01
Pages
164-73
Language
English
Region
United States
NLM ID
0374236
Subset
IM
Grants
NCI NIH HHS · U10-CA-12070 · United States
NCI NIH HHS · U10-CA37377 · United States
NCI NIH HHS · U10-CA39806 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]